Table 2.
M-mode, pulse wave Doppler, tissue Doppler echocardiographic, and strain characteristics of the patients and control group.
| Psoriasis patients(n = 20) | Healthy controls(n = 20) | P | |
| IVSD (mm) | 0.71 ± 0.065 | 0.68 ± 0.04 | <0.05 (0.01) |
| LVPWD (mm) | 0.75 ± 0.041 | 0.73 ± 0.038 | <0.05 (0.01) |
| LVESD (mm) | 33.8 ± 0.07 | 34.3 ± 0.08 | >0.05 |
| LVEDD (mm) | 45.7 ± 0.22 | 45.4 ± 0.13 | <0.05 (0.02) |
| SF (%) | 32.3 ± 1.8 | 32.8 ± 1.98 | >0.05 |
| EF (%) | 70 ± 2.5 | 69 ± 2.41 | >005 |
| Mitral E | 0.68 ± 0.07 | 0.76 ± 0.056 | <0.05 (0.003) |
| Mitral A | 0.43 ± 0.07 | 0.35 ± 0.06 | <0.05 (0.003) |
| E/A | 1.64 ± 0.22 | 2.17 ± 0.35 | <0.05 (0.02) |
| DEC time | 66 ± 8.9 | 63.3 ± 8.5 | >0.05 |
| TDI E’ | 0.62 ± 0.07 | 0.70 ± 0.02 | <0.05 (0.01) |
| TDI A’ | 0.50 ± 0.031 | 0.39 ± 0.036 | <0.05 (0.008) |
| E’/A’ | 1.34 ± 1.14 | 1.58 ± 1.88 | <0.05 (0.02) |
| S | 0.36 ± 0.033 | 0.36 ± 0.032 | >0.05 |
| IVRT | 57.9 ± 13.3 | 55.9 ± 6.42 | >0.05 |
| IVCT | 74.7 ± 6.65 | 75 ± 5.77 | <0.05 (0.02) |
| ET | 154.85 ± 3.57 | 137.95 ± 10.84 | <0.05 (0.02) |
| MPI | 1.00 ± 0.13 | 0.90 ± 0.13 | <0.05 (0.04) |
| Circumferential strain | –21.3 ± 3.75 | –23.6 ± 3.78 | <0.05 (0.05) |
| Longitudinal strain | –19.8 ± 1.89 | –23.4 ± 3.92 | <0.05 (0.004) |
E: Early diastolic mitral inflow velocity, A: late diastolic mitral inflow velocity, IVRT: isovolumetric relaxation time, IVCT: isovolumic contraction time, ET: ejection time, TDI: tissue Doppler imaging, IVSD: interventricular septum diameter, LVPWD: left ventricle posterior wall diameter, LVESD: left ventricle end-systolic diameter, LVEDD: left ventricle end-diastolic diameter, SF: shortening fraction, EF: ejection fraction, DEC time: deceleration time, MPI: myocardial performance index.